373
Views
7
CrossRef citations to date
0
Altmetric
Review

Unmet needs in treating laryngo-pharyngeal reflux disease: where do we go from here?

, &
Pages 995-1004 | Received 14 Jan 2016, Accepted 14 Apr 2016, Published online: 13 May 2016

References

  • Spechler SJ. Epidemiology and natural history of gastrooesophageal reflux disease. Digestion. 1992;51(1):24–29.
  • Vaezi MF. Therapy insight: gastroesophageal reflux disease and laryngopharyngeal reflux. Nat Clin Pract Gastroenterol Hepatol. 2005;2(12):595–603.
  • Vakil N, Van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–1920.
  • Vaezi MF, Hicks DM, Abelson TI, et al. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroengerol Hepatol. 2003;1(5):333–334.
  • Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135(4):1392–1413.
  • Francis DO, Rymer JA, Slaughter JC, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013;108(6):905–911.
  • Bulmer DM, Ali MS, Brownlee IA, et al. Laryngeal mucosa: its susceptibility to damage by acid and pepsin. Laryngoscope. 2010;120:777–778.
  • Adhami T, Goldblum JR, Richter JE, et al. Role of gastric and duodenal ingredients in laryngeal tissue injury: an experimental study in dogs. Am J Gastroenterol. 2004;99(11):2098–2106.
  • Loughlin CJ, Koufman JA, Averill DB, et al. Acid-induced laryngospasm in a canine model. Laryngoscope. 1996;106(12):1506–1509.
  • Johnston N, Well CW, Blumin JH, et al. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol. 2007;116(12):934–938.
  • Groen JN, Smout AJ. Supra-oesophageal manifestations of gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol. 2003;15(12):1339–1350.
  • Sontag SJ. The spectrum of pulmonary symptoms due to gastroesophageal reflux. Thoracic Surgery Clin. 2005;15(3):353–368.
  • Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope. 1991;101(4 pt 2 suppl 53):1–78.
  • Reimer C, Bytzer P. Management of laryngopharyngeal reflux with proton pump inhibitors. Ther Clin Risk Manag. 2008;4(1):225–233.
  • Guo H, Ma H, Wang J. Proton pump inhibitor therapy for the treatment of laryngopharyngeal reflux: a meta-analysis of randomized controlled trials. J Clin Gastroenterol. 2016;50(4):295–300.
  • Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–497.
  • Nilsson M, Johnsen R, Yu W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290(1):66–72.
  • Murray L, Johnston B, Lane A, et al. Relationship between body mass and gastro-oesophageal reflux symptoms: the Bristol Helicobacter Project. Int J Epidemiol. 2003;32(4):645–650.
  • Aslam M, Slaughter JC, Goutte M, et al. Nonlinear relationship between body mass index and esophageal acid exposure in the extraesophageal manifestations of reflux. Clin Gastroenterol Hepatol. 2012;10(8):874–878.
  • Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol. 2011;8(6):340–347.
  • Pandolfino JE, El–Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130(3):639–649.
  • Smith JE, Morjaria JB, Morice AH. Dietary intervention in the treatment of patients with cough and symptoms suggestive of airways reflux as determined by Hull airways Reflux Questionnaire. Cough. 2013;9:27.
  • Fraser-Moodie CA, Norton B, Gornall C, et al. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol. 1999;34(4):337–340.
  • Ness-Jensen E, Lindam A, Lagergren J, et al. Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol. 2013;108(3):376–382.
  • Mathus-Vliegen LM, Tytgat GN. Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension. Eur J Gastroenterol Hepatol. 1996;8(7):635–640.
  • Singh M, Lee J, Gupta N, et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring). 2013;21(2):284–290.
  • Varela JE, Hinojosa MW, Nguyen NT. Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surg Obes Relat Dis. 2009;5:139–143.
  • Tiktinsky E, Lantsberg L, Lantsberg S, et al. Gastric emptying of semisolids and pouch motility following laparoscopic adjustable gastric banding. Obes Surg. 2009;19(9):1270–1273.
  • Naef M, Mouton WG, Naef U, et al. Esophageal dysmotility disorders after laparoscopic gastric banding – an underestimated complication. Ann Surg. 2011;253(2):285–290.
  • Page MP, Kastenmeier A, Goldblatt M, et al. Medically refractory gastroesophageal reflux disease in the obese: what is the best surgical approach? Surg Endosc. 2014;28(5):1500–1504.
  • Wang G, Agenor K, Pizot J, et al. Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP). Obes Surg. 2012;22(8):1263–1267.
  • Mejıa-Rivas MA, Herrera-Lopez A, Hern Andez-Calleros J, et al. Gastroesophageal reflux disease in morbid obesity: the effect of Roux-en-Y gastric bypass. Obes Surg. 2008;18(10):1217–1224.
  • Frezza EE, Ikramuddin S, Gourash W, et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2002;16(7):1027–1031.
  • Nebel OT, Castell DO. Inhibition of the lower oesophageal sphincter by fat: a mechanism for fatty food intolerance. Gut. 1973;14(4):270–274.
  • Fox M, Barr C, Nolan S, et al. The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol. 2007;5(4):439–444.
  • Mone I, Kraja B, Bregu A, et al. Adherance to a predominantly Mediterranean diet decreases the risk of gastroesophageal reflux disease: a cross-sectional study in a South Eastern European population. Dis Esophagus. 2015;10:1111.
  • Koufman JA. Low-acid diet for recalcitrant laryngeal reflux: therapeutic benefits and their implications. Ann Otol Rhinol Laryngol. 2011;120(5):281–287.
  • Murphy D, Castell D. Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol. 1988;83(6):633–636.
  • Feldman M, Barnett C. Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn. Gastroenterology. 1995;108(1):125–131.
  • Pandeya N, Green A, Whiteman D. Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community. Dis Esophagus. 2012;25(7):573–583.
  • Nilsson M, Johnsen R, Ye W, et al. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut. 2004;53(12):1730–1735.
  • Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol. 2000;95(12):3374–3382.
  • Rubinstein E, Hauge C, Sommer P, et al. Oesophageal and gastric potential difference and pH in healthy volunteers following intake of coca-cola, red wine, and alcohol. Pharmacol Toxicol. 1993;72(1):61–65.
  • Kaufman S, Kaye M. Induction of gastro-oesophageal reflux by alcohol. Gut. 1978;19(4):336–338.
  • Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166(9):965–971.
  • DeVault K, Castell D. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100(1):190–200.
  • Piesman M, Hwang I, Maydonovitch C, et al. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter? Am J Gastroenterol. 2007;102(10):2128–2134.
  • Yang J, Kang H, Lee S, et al. Recurrence of gastroesophageal reflux disease correlated with a short dinner-to-bedtime interval. J Gastroenterol Hepatol. 2014;29(4):730–735.
  • Holloway R, Hongo M, Berger K, et al. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology. 1985;89(4):779–784.
  • Wu K, Rayner C, Chuah S, et al. Effect of liquid meals with different volumes on gastroesophageal reflux disease. J Gastroenterol Hepatol. 2014;29(3):469–473.
  • Stanciu C, Bennett J. Effects of posture on gastro-oesophageal reflux. Digestion. 1977;15(2):104–109.
  • Khoury RM, Camacho-Lobato L, Katz PO, et al. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol. 1999;94(8):2069–2073.
  • Hamilton JW, Boisen RJ, Yamamoto DT, et al. Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid. Dig Dis Sci. 1988;33(5):518–522.
  • Harvey R, Gordon P, Hadley N, et al. Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis. Lancet. 1987;2(8569):1200–1203.
  • Fletcher KC, Goutte M, Slaughter JC, et al. Significance and degree of reflux in patients with primary extraesophageal symptoms. Laryngoscope. 2011;121(12):2561–2565.
  • Hoppo T, Komatsu Y, Nieponice A, et al. Toward an improved understanding of isolated upright reflux: positional effects on the lower esophageal sphincter in patients with symptoms of gastroesophageal reflux. World J Surg. 2012;36(7):1623–1631.
  • Shay S, Conwell D, Mehindru V, et al. The effect of posture on gastroesophageal reflux event frequency and composition during fasting. Am J Gastroenterol. 1996;91(1):54–60.
  • Karim S, Jafri W, Faryal A, et al. Regular post dinner walk; can be a useful lifestyle modification for gastroesophageal reflux. J Pak Med Assoc. 2011;61(6):526–530.
  • Avidan B, Sonnenberg A, Schnell TG, et al. Walking and chewing reduce postprandial acid reflux. Aliment Pharmacol Ther. 2001;15(2):151–155.
  • Kraus BB, Sinclair JW, Castell DO. Gastroesophageal reflux in runners. Characteristics and treatment. Ann Intern Med. 1990;112(6):429–433.
  • Clark C, Kraus B, Sinclair J, et al. Gastroesophageal reflux induced by exercise in healthy volunteers. JAMA. 1989;261(24):3599–3601.
  • Qadeer MA, Colabianchi N, Strome M, et al. Gastroesophageal reflux and laryngeal cancer: causation or association? A critical review. Am J Otolaryngol. 2006;27(2):119–128.
  • Smit CF, Copper MP, Van Leeuwen JA, et al. Effect of cigarette smoking on gastropharyngeal and gastroesophageal reflux. Ann Otol Rhinol Laryngol. 2001;110(2):190–193.
  • Dua K, Bardan E, Ren J, et al. Effect of chronic and acute cigarette smoking on the pharyngo-upper oesophageal sphincter contractile reflex and reflexive pharyngeal swallow. Gut. 1998;43(4):537–541.
  • Kahrilas P, Gupta R. Mechanisms of acid reflux associated with cigarette smoking. Gut. 1990;31(1):4–10.
  • Ness-Jensen E, Lindam A, Lagergren J, et al. Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study: the HUNT study. Am J Gastroenterology. 2014;109(2):171–177.
  • Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope. 2006;116(2):254–260.
  • Qadeer M, Phillips CO, Lopez AR, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006;101(11):2646–2654.
  • Martinucci I, De Bertoli N, Savarino E, et al. Optimal treatment of laryngopharyngeal reflux. Ther Adv Chronic Dis. 2013;4(6):287–301.
  • Lam PK, Ng ML, Cheung TK, et al. Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol. 2010;8(9):770–776.
  • Shaheen NJ, Crockett SD, Bright SD, et al. Randomised clinical trial: high-dose acid suppression for chronic cough – a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011;33(2):225–234.
  • Campagnolo AM, Priston J, Thoen, RH, et al. Laryngopharyngeal reflux: diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol. 2014;18(2):184–191.
  • Dettmar PW, Hampson FC, Taubel J, et al. The suppression of gastro-oesophageal reflux by alginates. Int J Clin Pract. 2007;61(10):1654–1662.
  • McGlashan JA, Johnstone LM, Sykes J, et al. The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. 2009;266(2):243–251.
  • Lindow SW, Regnell P, Sykes J, et al. An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy. Int J Clin Pract. 2003;57:175–179.
  • Bastian RW, Vaidya AM, Delsupehe KG. Sensory neuropathic cough: a common and treatable cause of chronic cough. Otolaryngol Head Neck Surg. 2006;135(1):17–21.
  • Cobeta I, Pacheco A, Mora E. The role of the larynx in chronic cough. Acta Otorrinolaringol Esp. 2013;64(5):363.
  • Norris BK, Schweinfurth JM. Management of recurrent laryngeal sensory neuropathic symptoms. Ann Otol Rhinol Laryngol. 2010;119(3):188.
  • Mintz S, Lee JK. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med. 2006;119(5):e13–e155.
  • Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380(9853):1583–1589.
  • Halum SL, Sycamore DL, McRae BR. A new treatment option for laryngeal sensory neuropathy. Laryngoscope. 2009;119(9):1844–1847.
  • Simon B, Ravelli GP, Goffin H. Sucralfate gel versus placebo in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1996;10(3):441–446.
  • Vaezi MF, Fass R, Reasner D, et al. IW-3718, a novel gastric retentive bile acid sequestrant improved symptoms of refractory GERD in a double blind placebo controlled phase 2a study. Am J Gastroenterol. 2015;110:A1661.
  • Telem DA, Rattner DW. Gastroesophageal reflux disease. In: Cameron, current surgical therapy. 11th ed. Philadelphia (PA): Elsevier Saunders; 2014. p. 9–14.
  • Klaus A, Swain JM, Hinder RA. Laparoscopic antireflux surgery for supraesophageal complications of gastroesophageal reflux disease. Am J Med. 2001;111(8):202S–206S.
  • Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305(19):1969–1977.
  • Hatlebakk JG, Zerbib F, Bruley Des Varannes S, et al. Gastroesophageal acid reflux control 5 years after antireflux surgery, compared with long-term esomeprazole therapy. Clin Gastroenterol Hepatol. 2016; 14(5):678–685.
  • Wright RC, Rhodes KP. Improvement of laryngopharyngeal reflux symptoms after laparoscopic Hill repair. Am J Surg. 2003;185(5):455–461.
  • Salminen P, Sala E, Koskenvuo J, et al. Reflux laryngitis: a feasible indication for laparoscopic antireflux surgery? Surg Laparosc Endosc Percutan Tech. 2007;17(2):73–78.
  • Weber B, Portnoy JE, Castellanos A, et al. Efficacy of anti-reflux surgery on refractory laryngopharyngeal reflux disease in professional voice users: a pilot study. J Voice. 2014;28(4):492–500.
  • Krill JT, Naik RD, Higginbotham T, et al. The predictors of response to antireflux surgery. Gastroenterology. 2016;150(4):S111. doi:10.1016/S0016-5085(16)30478-4.
  • Swoger J, Ponsky J, Hicks DM, et al. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol. 2006;4(4):433–441.
  • Francis DO, Goutte M, Slaughter JC, et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope. 2011;121(9):1902–1909.
  • Kavitt RT, Vaezi MF. Gastroesophageal reflux laryngitis, in the esophagus. Richter JE, Castell DO, editors; 5th ed. Oxford: Wiley-Blackwell; 2002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.